Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (31)
Kathryn B. Holroyd & Aaron L. Berkowitz. (2024) Metabolic and Toxic Myelopathies. CONTINUUM: Lifelong Learning in Neurology 30:1, pages 199-223.
Crossref
Crossref
Sandeep Mundhra, Srikant Mohta, Shivanand Gamanagatti, Sanchit Sharma, Naren Hemachandran & Anoop Saraya. (2023) Recanalized Paraumbilical Vein Leading to Hepatic Myelopathy Causing Spastic Paraparesis in a Patient with Chronic Liver Disease. Journal of Clinical and Experimental Hepatology 13:2, pages 372-376.
Crossref
Crossref
Chun-Yan Chang, Chen Liu, Fang-Fang Duan, Hang Zhai, Shan-Shan Song & Song Yang. (2022) Spontaneous remission of hepatic myelopathy in a patient with alcoholic cirrhosis: A case report. World Journal of Clinical Cases 10:30, pages 11172-11177.
Crossref
Crossref
Michaël C. C. Slama & Aaron L. Berkowitz. (2021) Metabolic and Toxic Myelopathies. Seminars in Neurology 41:03, pages 309-326.
Crossref
Crossref
Rodolfo Costa & Sara Montagnese. (2021) The role of astrocytes in generating circadian rhythmicity in health and disease. Journal of Neurochemistry 157:1, pages 42-52.
Crossref
Crossref
S. D. Podymova. (2021) New approaches to the pathogenesis, clinic, and treatment of hepatic encephalopathy. Terapevticheskii arkhiv 93:2, pages 236-242.
Crossref
Crossref
Judit Vidal-González, Sergi Quiroga, Macarena Simón-Talero & Joan Genescà. (2020) Spontaneous portosystemic shunts in liver cirrhosis: new approaches to an old problem. Therapeutic Advances in Gastroenterology 13, pages 175628482096128.
Crossref
Crossref
Kang Liu, Gang Chen, Shu-Yao Ren, Yuan-Qiang Zhu, Tian-Lei Yu, Ping Tian, Chen Li, Yi-Bin Xi, Zheng-Yu Wang, Jian-Jun Ye, Guo-Hong Han & Hong Yin. (2019) Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study. Neural Regeneration Research 14:5, pages 850.
Crossref
Crossref
Mohamed M. Amin. 2019. Dietary Interventions in Liver Disease. Dietary Interventions in Liver Disease
31
38
.
Hongwei Zhao, Zhendong Yue, Lei Wang, Zhenhua Fan, Fuliang He, Xiaoqun Dong & Fuquan Liu. (2018) Benefits of Early Treatment for Patients with Hepatic Myelopathy Secondary to TIPS: A Retrospective Study in Northern China. Scientific Reports 8:1.
Crossref
Crossref
Marsha Y. Morgan. 2018. Sherlock's Diseases of the Liver and Biliary System. Sherlock's Diseases of the Liver and Biliary System
151
179
.
Paolo Feltracco, Annachiara Cagnin, Cristiana Carollo, Stefania Barbieri & Carlo Ori. (2017) Neurological disorders in liver transplant candidates: Pathophysiology and clinical assessment. Transplantation Reviews 31:3, pages 193-206.
Crossref
Crossref
Hongwei Zhao, Fuquan Liu, Zhendong Yue, Lei Wang & Zhenhua Fan. (2016) Evaluation of mid- and long-term efficacy of shunt limiting for hepatic myelopathy after transjugular intrahepatic portosystemic shunt. Clinics and Research in Hepatology and Gastroenterology 40:4, pages 440-446.
Crossref
Crossref
Samyadip Chakraborty & David Dobrzykowski. (2014) Examining Value Co-Creation in Healthcare Purchasing: a Supply Chain View. Verslas: teorija ir praktika 15:2, pages 179-190.
Crossref
Crossref
Inga Šatinskienė & Eugenijus Lesinskas. (2014) PRIEŪMINIO IDIOPATINIO NEUROSENSORINIO KLAUSOS PAŽEIDIMO PROGNOSTINIAI VEIKSNIAI. Sveikatos mokslai 24:2, pages 75-82.
Crossref
Crossref
Andrius Macas & Diana Bilskienė. (2014) MULTIMODALINIO NEUROMONITORINGO IR KITŲ VEIKSNIŲ PRITAIKYMAS GALVOS SMEGENŲ TRAUMOS BAIGTIMS PROGNOZUOTI. Sveikatos mokslai 24:2, pages 52-59.
Crossref
Crossref
Lindsay Hinkle-Johnston & Joseph M. Ferrara. 2014. Movement Disorders in Neurologic and Systemic Disease. Movement Disorders in Neurologic and Systemic Disease
144
171
.
Suzanne M. de la Monte & Jillian J. Kril. (2013) Human alcohol-related neuropathology. Acta Neuropathologica 127:1, pages 71-90.
Crossref
Crossref
Deepak Jain, Ankur Arora, Pranjal Deka, Amar Mukund, Shorav Bhatnagar, Deepti Jindal, Niteen Kumar & Viniyendra Pamecha. (2012) Treatment of Portosystemic Shunt Myelopathy with a Stent Graft Deployed through a Transjugular Intrahepatic Route. CardioVascular and Interventional Radiology 36:4, pages 1161-1164.
Crossref
Crossref
Prasanna K.S. Rao, Keyur A. Sheth, Raghunandan Nadig, Mallikarjun Patil & Adarsh K. Channagiri. (2012) Portosystemic Myelopathy: A Rare Neurological Presentation of Portosystemic Shunts. Journal of Clinical and Experimental Hepatology 2:4, pages 393-395.
Crossref
Crossref
Liudmila Kimševaitė. (2012) Neurologinės kepenų ir tulžies pūslės ligų manifestacijosNeurological Manifestations in Patients with Liver and Gall Bladder Diseases. Sveikatos mokslai 22:1, pages 104-112.
Crossref
Crossref
Marsha Y. Morgan. 2011. Sherlock's Diseases of the Liver and Biliary System. Sherlock's Diseases of the Liver and Biliary System
121
151
.
Dirk Enneking. (2011) The nutritive value of grasspea (Lathyrus sativus) and allied species, their toxicity to animals and the role of malnutrition in neurolathyrism. Food and Chemical Toxicology 49:3, pages 694-709.
Crossref
Crossref
R. Fernández‐Rodriguez, A. Contreras, J. G. De Villoria & F. Grandas. (2010) Acquired hepatocerebral degeneration: clinical characteristics and MRI findings. European Journal of Neurology 17:12, pages 1463-1470.
Crossref
Crossref
Cary Caldwell, Norman Werdiger, Sofia Jakab, Michael Schilsky, Antonios Arvelakis, Sanjay Kulkarni & Sukru Emre. (2010) Use of model for end-stage liver disease exception points for early liver transplantation and successful reversal of hepatic myelopathy with a review of the literature. Liver Transplantation 16:7, pages 818-826.
Crossref
Crossref
Mikio Kajihara, Sara Montagnese, Pooja Khanna, Piero Amodio, Anthony H.V. Schapira, Geoffrey M. Dusheiko & Marsha Y. Morgan. (2010) Parkinsonism in patients with chronic hepatitis C treated with interferon-α2b: a report of two cases. European Journal of Gastroenterology & Hepatology 22:5, pages 628-631.
Crossref
Crossref
J. Ferrara & J. Jankovic. (2009) Acquired hepatocerebral degeneration. Journal of Neurology 256:3, pages 320-332.
Crossref
Crossref
Y H Yin, Z J Ma, Y H Guan, Y D Ren & Z L Zhang. (2009) Clinical features of hepatic myelopathy in patients with chronic liver disease. Postgraduate Medical Journal 85:1000, pages 64-68.
Crossref
Crossref
Bahaa Eldeen Senousy & Peter V Draganov. (2009) Evaluation and management of patients with refractory ascites. World Journal of Gastroenterology 15:1, pages 67.
Crossref
Crossref
Neeraj Kumar. (2008) METABOLIC AND TOXIC MYELOPATHIES. CONTINUUM: Lifelong Learning in Neurology 14, pages 91-115.
Crossref
Crossref
Ja Eun KooYoung-Suk LimSun Jeong MyungKyung Suk SuhKang Mo KimHan Chu LeeYoung-Hwa ChungYung Sang LeeDong Jin Suh. (2008) Hepatic myelopathy as a presenting neurological complication in patients with cirrhosis and spontaneous splenorenal shunt. The Korean Journal of Hepatology 14:1, pages 89.
Crossref
Crossref